Copyright
©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Jun 14, 2005; 11(22): 3457-3460
Published online Jun 14, 2005. doi: 10.3748/wjg.v11.i22.3457
Published online Jun 14, 2005. doi: 10.3748/wjg.v11.i22.3457
Table 1 Baseline values in four patients before treatment.
No. (k) | Age (yr) (x1) | Course of jaundice (mo) (x2) | Toughness degree of liver (x3) | Liver below costal arch (cm) (x4) | Liver below xiphoid (cm) (x5) | Splenomegaly (cm) (x6) |
1 | 55 | 5.0 | 3 | 3 | 6 | 0 |
2 | 43 | 2.0 | 2 | 3 | 7 | 1 |
3 | 27 | 0.7 | 2 | 6 | 4 | 4 |
4 | 48 | 1.0 | 3 | 2 | 0 | 2 |
Table 2 Hepatic functions in four patients before and after albendazole treatment.
No. (k) | Bilirubin (mmol/L) (x7) | One minute bilirubin (mmol/L) (x8) | ALP (IU) (x9) | GOT (x10) | A/G (g/L) (x11) | |||||
Before | After | Before | After | Before | After | Before | After | Before | After | |
1 | 89.2 | 14.2 | 11.3 | 2.1 | 176.6 | 28.4 | 30.0 | 30.0 | 45.5/37.5 | 44.2/27.5 |
2 | 60.2 | 8.9 | 8.0 | 0.5 | 58.0 | 51.0 | 76.0 | 30.0 | 41.0/56.0 | 45.1/33.9 |
3 | 62.0 | 8.9 | 23.4 | 0.9 | 481.0 | 10.6 | 72.0 | 63.0 | 28.0/54.0 | 48.0/36.0 |
4 | 212.9 | 17.0 | 129.2 | 1.9 | 463.0 | 247.0 | 135.0 | 30.0 | 33.0/45.0 | 45.0/27.0 |
Table 3 Improved ratio of hepatic functions after treatment.
k | x7 | x8 | x9 | x10 | x11 |
1 | 0.84081 | 0.81416 | 0.83902 | 0.00000 | 0.32468 |
2 | 0.85216 | 0.93750 | 0.12069 | 0.60526 | 0.81711 |
3 | 0.98074 | 0.96154 | 0.97796 | 0.12500 | 1.57141 |
4 | 0.92015 | 0.98529 | 0.46652 | 0.77778 | 1.27274 |
Table 4 Results of correlation analysis.
x7 | x8 | x9 | x10 | x11 | |
x1 | -0.81774 | -0.59309 | -0.27907 | 0.10911 | -0.77759 |
0.1823 | 0.4069 | 0.7209 | 0.8909 | 0.2224 | |
x2 | -0.78666 | -0.98054 | 0.15755 | -0.56181 | -0.98954 |
0.2133 | 0.0195 | 0.8425 | 0.4382 | 0.0105 | |
x3 | -0.31909 | -0.37737 | 0.15463 | 0.06341 | -0.45498 |
0.6809 | 0.6226 | 0.8454 | 0.9366 | 0.5450 | |
x4 | 0.66573 | 0.12652 | 0.63044 | -0.59213 | 0.40379 |
0.3343 | 0.8735 | 0.3696 | 0.4079 | 0.5962 | |
x5 | -0.56410 | -0.60064 | -0.11905 | -0.52589 | -0.57561 |
0.4359 | 0.3994 | 0.8810 | 0.4741 | 0.4244 | |
x6 | 0.97814 | 0.72219 | 0.38317 | 0.03476 | 0.90090 |
0.0219 | 0.2778 | 0.6168 | 0.9652 | 0.0991 |
Table 5 Raw data in four groups.
Group (i) k | n | n | Disappearance of symptoms | Eradication of H pylori | Active mucitis fading | Ulcer cure | ||||
Rate (%) (1) | Time (d) (2) | n | Rate (%) (3) | n | Rate (%) (4) | n | Rate (%) (5) | |||
A (x1) | 14 | 14 | 100 | 3.8 | 11 | 78.6 | 9/13 | 69.2 | 12 | 85.7 |
B (x2) | 15 | 15 | 100 | 3.6 | 10 | 66.7 | 9/13 | 69.2 | 11 | 73.3 |
C (x3) | 14 | 10 | 71.4a | 6.8 | 11 | 78.6 | 9/12 | 75 | 9 | 64.3 |
D (x4) | 15 | 15 | 100 | 3.7 | 2 | 13.3b | 3/12 | 25 | 9 | 60 |
Ideal (x0) | 100 | 3.6 | 78.6 | 75 | 85.7 |
Table 6 Gray relational coefficients between ideals (x0) and other groups (xi).
Group (i) k | Disappearance of symptoms | Eradication of H pylori | Active mucitis fadin | Ulcer cure | |
Rate (%) (1) | Time (d) (2) | Rate (%) (3) | Rate (%) (4) | Rate (%)(5) | |
A (1) | 1 | 0.9175 | 1 | 0.8481 | 1 |
B (2) | 1 | 1 | 0.7328 | 0.8481 | 0.7547 |
C (3) | 0.6302 | 0.4099 | 1 | 1 | 0.6407 |
D (4) | 1 | 0.9569 | 0.3333 | 0.3932 | 0.6013 |
Table 7 Clinical materials of the subjects (mean±SD).
Groups | Number of subjects | Age (yr) | Number of males |
Controls | 30 | 31.7±7.2 | 19 |
CPH | 28 | 35.2±9.1 | 20 |
CAH | 21 | 34.9±6.9 | 16 |
LC | 51 | 45.11±1.4 | 41 |
Table 8 Sensitivity of serum PC III, PLD and HA.
Marker | CPH | CAH | LC |
PC III | 28.6 | 100.0 | 88.2 |
PLD | 0.0 | 57.1 | 90.2 |
HA | 7.1 | 76.2 | 94.2 |
- Citation: Tan XR, Li YG, Chen MZ. Applications of gray relational analysis in gastroenterology. World J Gastroenterol 2005; 11(22): 3457-3460
- URL: https://www.wjgnet.com/1007-9327/full/v11/i22/3457.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i22.3457